4.1 Review

SARS: Lessons learned from other coronaviruses

期刊

VIRAL IMMUNOLOGY
卷 16, 期 4, 页码 461-474

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/088282403771926292

关键词

-

资金

  1. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017418, R01AI047800] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030606, R01NS021954] Funding Source: NIH RePORTER
  3. NIAID NIH HHS [AI 47800, AI17418] Funding Source: Medline
  4. NINDS NIH HHS [NS30606, NS21954] Funding Source: Medline
  5. CSR NIH HHS [RG2585B5] Funding Source: Medline

向作者/读者索取更多资源

The identification of a new coronavirus as the etiological agent of severe acute respiratory syndrome (SARS) has evoked much new interest in the molecular biology and pathogenesis of coronaviruses. This review summarizes present knowledge on coronavirus molecular biology and pathogenesis with particular emphasis on mouse hepatitis virus (MHV). MHV, a member of coronavirus group 2, is a natural pathogen of the mouse; MHV infection of the mouse is considered one of the best models for the study of demyelinating disease, such as multiple sclerosis, in humans. As a result of the SARS epidemic, coronaviruses can now be considered as emerging pathogens. Future research on SARS needs to be based on all the knowledge that coronavirologists have generated over more than 30 years of research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据